| Janssen-Cilag AG - Stelara 130 mg, Konzentrat zur Herstellung einer Infusionslösung | | 66135 | | 01 | | Stelara 130 mg | | Konzentrat zur Herstellung einer Infusionslösung | | L04AC05 | | Ustekinumab | | 02.06.2017 | | |
| | Composition | | ustekinumabum 130 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 80, dinatrii edetas, antiox.: methioninum, aqua ad iniectabilia q.s. ad solutionem pro 26 ml. | | Packungsbestandteile | | Concentrate for infusion | | | | | | Active Agent | Dose |
|---|
| Ustekinumabum | 130mg / 26ml |
| | | | Inactive agents | | additional_information |
|---|
| Dinatrii Edetas | | | | Histidin Hydrochloride Monohydrate | | | | Histidine | | | | Methionine | | antiox. | | Polysorbatum 80 | | | | Saccharum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 3233.32 | 3560.15 | B | SL | No |
|
|
